Inventor · disambiguated record
Thomas Sun
Also filed as: SUN THOMAS · SUN THOMAS W · SUN THOMAS WEITAO
29 granted patents·8 pending applications·496 citations·filing 1998–2020
97Inventor score
Files withRIGEL PHARMACEUTICALS INC21SINGH RAJINDER4BHAMIDIPATI SOMASEKHAR3SYNTEX LLC3UNIV LELAND STANFORD JUNIOR2
Top patents by PatentIndex Score
37 records- 0199US7449458B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Nov 11, 2008·108 cites·13 claims
- 0298US7563892B1Prodrugs of 2,4 pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jul 21, 2009·52 cites·8 claims
- 0397US8163902B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2007·Granted Apr 24, 2012·35 cites·22 claims
- 0497US7538108B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted May 26, 2009·43 cites·19 claims
- 0595US8211889B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2012·Granted Jul 3, 2012·17 cites·8 claims
- 0695US8211888B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2011·Granted Jul 3, 2012·19 cites·9 claims
- 0794US7153880B2Substituted diphenyl heterocycles useful for treating HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Dec 26, 2006·68 cites·15 claims
- 0893US6759538B2Substituted diphenyl heterocycles useful for treating HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jul 6, 2004·71 cites·34 claims
- 0990US8785437B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·7 cites·8 claims
- 1088US8476263B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2012·Granted Jul 2, 2013·5 cites·10 claims
- 1188US6184242B12-(substituted-phenyl)amino-imidazoline derivativesSYNTEX USA LLC·Filed 1998·Granted Feb 6, 2001·31 cites·6 claims
- 1285US8372415B2Wet granulation using a water sequestering agentRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Feb 12, 2013·7 cites·7 claims
- 1384US9737554B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Aug 22, 2017·2 cites·11 claims
- 1484US9532998B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesSINGH RAJINDER·Filed 2016·Granted Jan 3, 2017·2 cites·24 claims
- 1584US9266912B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·3 cites·24 claims
- 1683US8263122B2Wet granulation using a water sequestering agentSUN THOMAS·Filed 2008·Granted Sep 11, 2012·5 cites·16 claims
- 1782US10577381B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 3, 2020·1 cites·24 claims
- 1881US9283238B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Mar 15, 2016·2 cites·7 claims
- 1980US8912170B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·2 cites·28 claims
- 2079US8445485B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2012·Granted May 21, 2013·2 cites·23 claims
- 2177USRE47034ETopical formulation for administering a compoundRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 11, 2018·2 cites·32 claims
- 2274US2020270271A1Prodrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2373US9040061B2Topical formulation for administering a compoundRIGEL PHARMACEUTICALS INC·Filed 2012·Granted May 26, 2015·2 cites·28 claims
- 2472USRE48898EProdrugs of 2,4-pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jan 25, 2022·0 cites·11 claims
- 2572US7141584B22-(substituted-phenyl)amino-imidazoline derivativesROCHE PALO ALTO LLC·Filed 2003·Granted Nov 28, 2006·3 cites·9 claims
- 2672US6596876B22-(substituted-phenyl)amino-imidazoline derivativesSYNTEX LLC·Filed 2002·Granted Jul 22, 2003·3 cites·20 claims
- 2772US6472536B12-(substituted-phenyl)amino-imidazoline derivativesSYNTEX LLC·Filed 2000·Granted Oct 29, 2002·3 cites·9 claims
- 2870US2020016179A1Prodrugs of 2,4-Pyrimidinediamine Compounds and Their UsesRIGEL PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2967US10357505B2Prodrugs of 2,4-pyrimidinediamine compounds and their usesBHAMIDIPATI SOMASEKHAR·Filed 2017·Granted Jul 23, 2019·0 cites·2 claims
- 3066US2017291909A1Prodrugs of 2,4-Pyrimidinediamine Compounds and Their UsesRIGEL PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3163US6693200B22-(substituted-phenyl)amino-imidazoline derivativesSYNTEX LLC·Filed 2003·Granted Feb 17, 2004·1 cites·10 claims
- 3259US8652492B2Wet granulation using a water sequestering agentRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Feb 18, 2014·0 cites·9 claims
- 3352US2018064646A1Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamineRIGEL PHARMACEUTICAL INC·Filed 2017·Application pending·0 cites
- 3448US2013102596A1Method and device for administering xinafoate salt of n4-(2,2-difluoro-4h-benzo [1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3- (methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamineRIGEL PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3546US2022062233A1Compounds for the Reduction of the Deleterious Activity of Extended Nucleotide Repeat Containing GenesUNIV LELAND STANFORD JUNIOR·Filed 2019·Application pending·0 cites
- 3644US2014206708A1Composition for ophthalmic administrationRIGEL PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3738US2020147069A1Compounds for The Reduction of The Deleterious Activity of Extended Nucleotide Repeat Containing GenesUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →